The state of Massachusetts currently has 2 active clinical trials seeking participants for Hereditary Angioedema (HAE) research studies. These trials are conducted in various cities, including Boston, Worcester, Springfield and Burlington.
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
Recruiting
The purpose of this study is to evaluate the long-term safety and efficacy of donidalorsen in people with HAE and the effects of donidalorsen on the number of HAE attacks and their impact on quality of life (QoL).
Gender:
All
Ages:
12 years and above
Trial Updated:
06/14/2024
Locations: Ionis Investigative Site, Boston, Massachusetts
Conditions: Hereditary Angioedema
A Study of STAR-0215 in Participants With Hereditary Angioedema
Recruiting
The goal of this clinical trial is to test the drug STAR-0215 in participants with hereditary angioedema (HAE). One group of participants will get 1 dose of STAR-0215, and two other groups will get 2 doses of STAR-0215. Researchers will study the effects of STAR-0215 in participants with HAE as this is the first time that the drug has been given to participants with HAE.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/26/2024
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Hereditary Angioedema